Squarepoint Ops LLC Pfizer Inc Transaction History

Squarepoint Ops LLC

$59.6 Billion
Q2 2024

A detailed history of Squarepoint Ops LLC transactions in Pfizer Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 667,800 shares of PFE stock, worth $18.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

667,800

Previous 1,292,100 48.32%

Holding current value

$18.3 Million

Previous $35.9 Million 47.89%

% of portfolio

0.03%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $21.1 Million - $24.7 Million	-835,554 Reduced 52.79%	747,128 $20.9 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $45.3 Million - $52 Million	-1,748,539 Reduced 52.49%	1,582,682 $43.9 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $49 Million - $63.7 Million	1,875,537 Added 128.84%	3,331,221 $95.9 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $9.71 Million - $11.2 Million	268,818 Added 22.65%	1,455,684 $53.4 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $35.6 Million - $46.3 Million	902,536 Added 317.43%	1,186,866 $48.4 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $35.7 Million - $46.5 Million	-853,957 Reduced 75.02%	284,330 $14.6 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $37.3 Million - $45.5 Million	851,577 Added 297.02%	1,138,287 $49.8 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $6.06 Million - $7.18 Million	-130,206 Reduced 31.23%	286,710 $15 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $12.7 Million - $15.8 Million	-278,183 Reduced 40.02%	416,916 $21.6 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $20.9 Million - $31 Million	-505,694 Reduced 42.11%	695,099 $41 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $31.8 Million - $40.8 Million	808,951 Added 206.45%	1,200,793 $51.6 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $11.3 Million - $12.8 Million	-315,241 Reduced 44.58%	391,842 $15.3 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $549,872 - $620,145	16,419 Added 2.38%	707,083 $25.6 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $14.7 Million - $18.7 Million	438,496 Added 173.89%	690,664 $25.4 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $35.2 Million - $41.3 Million	-1,108,624 Reduced 81.47%	252,168 $9.26 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $31.8 Million - $38.6 Million	1,055,523 Added 345.77%	1,360,792 $44.5 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $39.3 Million - $56.1 Million	-1,453,604 Reduced 82.64%	305,269 $9.96 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $16.3 Million - $18.5 Million	495,562 Added 39.23%	1,758,873 $68.9 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $38.2 Million - $49.6 Million	1,177,013 Added 1363.89%	1,263,311 $45.4 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $1.08 Million - $1.21 Million	-29,246 Reduced 25.31%	86,298 $3.74 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $4.33 Million - $4.76 Million	115,544 New	115,544 $4.91 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $642,756 - $732,812	-16,708 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $5.37 Million - $6.52 Million	-155,879 Reduced 90.32%	16,708 $736,000
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $16.9 Million - $18 Million	-511,116 Reduced 74.76%	172,587 $6.26 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $3.53 Million - $4.09 Million	-110,570 Reduced 13.92%	683,703 $24.3 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $21.9 Million - $23.3 Million	659,173 Added 487.91%	794,273 $28.8 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $4.19 Million - $4.61 Million	135,100	135,100 $4.82 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Pfizer Inc Transaction History